• Contact Us
  • About
  • Advertise
  • Careers
Kashmir Dot Com
  • Home
  • Kashmir
  • Jammu
  • World
  • Politics
  • Opinion
  • Business
  • Health
  • Contact Us
No Result
View All Result
  • Home
  • Kashmir
  • Jammu
  • World
  • Politics
  • Opinion
  • Business
  • Health
  • Contact Us
No Result
View All Result
Kashmir Dot Com
No Result
View All Result
Home Health

Cipla receives final USFDA nod for Lanreotide injection to treat tumours

Kashmir Dot Com by Kashmir Dot Com
May 22, 2024
in Health
0
Cipla receives final USFDA nod for Lanreotide injection to treat tumours
0
SHARES
32
VIEWS
Share on Facebook

Mumbai, May 22: Drugmaker Cipla on Wednesday announced that the US Food and Drug Administration (USFDA) has granted it final approval for the Lanreotide injection, used for the treatment of acromegaly and gastroenteropancreatic neuroendocrine tumours (GEP-NETs).

Acromegaly is a hormonal disorder, while GEP-NETs is a rare type of tumour that can form in the pancreas or other parts of the gastrointestinal tract, including the stomach, small intestine, colon, rectum, and appendix.

The company said it has received final approval for Lanreotide injection in doses 120 mg/0.5 mL, 90 mg/0.3 mL, and 60 mg/0.2 mL.

It added that the USFDA approval is based on an Abbreviated New Drug Application (NDA).

Previous Post

Gurez-Bandipora road to re-open for two way traffic from May 23

Next Post

KPDCL urges domestic consumers to avail interest waiver under Power Amnesty Scheme

Next Post
Amid country’s worst power crisis J&K rushes to tackle electricity shortage

KPDCL urges domestic consumers to avail interest waiver under Power Amnesty Scheme

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

ADVERTISEMENT

LATEST NEWS

Centre Transfers Three IAS Officers from Delhi to Jammu and Kashmir

J&K SEC Shantmanu attends meeting with President at Rashtrapati Bhavan

Spl Secy Cabinet Secretariat reviews deregulation reforms with Chief Secretary Dr. Sajjan

IndiGo cancels Saudi Arabia flights till Nov 30

FDA Seals Hattrick’s Storage Area in Rajbagh Over Food Safety Violations; 69 Inspections Conducted Across J&K

JKSA Slams BGSBU VC Over Invitation to RSS Pracharak Indresh Kumar as Chief Guest, Seeks Probe

SMC Seals Unauthorised Car Washing Centre in Srinagar’s Natipora

NIT Srinagar selects three teams for National-Level Design for Bharat 2027 challenge

Article 21 means nothing but lip service if police fancy dictates preventive detention: J&K High Court

Only Handful of Foreign Terrorists Remain in J&K, UT Will Soon Be Terror-Free: LG Sinha

Facebook Twitter

About Us

Kashmir Dot Com (KDC) is J&K's premier News Agency having a vast reach of audience.

Kashmir Dot Com is a News Agency based in Srinagar, J&K that offers syndicated multimedia news feed to plethora of news-bureaus in J&K and beyond. We also provide a range of facilities from foreign and domestic channels to package their reports in Jammu and Kashmir. We cover almost all areas of interest in J&K to viewers including news, entertainment, and life styles, bussiness, sports, human-interest features and social and developmental issues.

KDC can well and truly take pride in the legacy of it's work, and in it's contribution towards the building of a free and fair Press in Jammu and Kashmir.

Category

  • Business
  • Entertainment
  • Health
  • JAMMU
  • Kashmir
  • Lead
  • National
  • Opinion
  • Politics
  • Science
  • Sports
  • Tech
  • Uncategorized
  • World

Company Info

  • Contact Us
  • About
  • Advertise
  • Careers

© 2026 JNews - Premium WordPress news & magazine theme by Jegtheme.

error: Content is protected !!
No Result
View All Result
  • Home
  • Kashmir
  • Jammu
  • World
  • Politics
  • Opinion
  • Business
  • Health
  • Contact Us

© 2026 JNews - Premium WordPress news & magazine theme by Jegtheme.